Pericarditis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials
• Forums

Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis
Condition:   Recurrent Pericarditis Interventions:   Biological: RPH-104;   Drug: Placebo Sponsors:   R-Pharm Overseas, Inc.;   DM 365, LLC;   Keystat, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2021 Category: Research Source Type: clinical trials